New Zealand markets open in 4 hours 13 minutes

West Pharmaceutical Services, Inc. (WST)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
313.14+3.96 (+1.28%)
As of 01:46PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 22.43B
Enterprise value 22.29B
Trailing P/E 43.98
Forward P/E 40.98
PEG ratio (5-yr expected) 5.36
Price/sales (ttm)8.01
Price/book (mrq)8.70
Enterprise value/revenue 7.75
Enterprise value/EBITDA 29.16

Trading information

Stock price history

Beta (5Y monthly) 1.01
52-week change 3-17.40%
S&P500 52-week change 329.75%
52-week high 3413.70
52-week low 3265.00
50-day moving average 3304.26
200-day moving average 3345.02

Share statistics

Avg vol (3-month) 3582.35k
Avg vol (10-day) 3383.36k
Shares outstanding 572.54M
Implied shares outstanding 672.54M
Float 872.06M
% held by insiders 10.58%
% held by institutions 196.14%
Shares short (30 Aug 2024) 41.53M
Short ratio (30 Aug 2024) 42.9
Short % of float (30 Aug 2024) 42.76%
Short % of shares outstanding (30 Aug 2024) 42.11%
Shares short (prior month 31 Jul 2024) 41.18M

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 40.26%
Trailing annual dividend rate 30.79
Trailing annual dividend yield 30.26%
5-year average dividend yield 40.25
Payout ratio 411.24%
Dividend date 307 Aug 2024
Ex-dividend date 431 Jul 2024
Last split factor 22:1
Last split date 327 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 18.25%
Operating margin (ttm)18.45%

Management effectiveness

Return on assets (ttm)10.66%
Return on equity (ttm)19.72%

Income statement

Revenue (ttm)2.88B
Revenue per share (ttm)39.01
Quarterly revenue growth (yoy)-6.90%
Gross profit (ttm)N/A
EBITDA 756.8M
Net income avi to common (ttm)524.9M
Diluted EPS (ttm)7.02
Quarterly earnings growth (yoy)-28.20%

Balance sheet

Total cash (mrq)446.2M
Total cash per share (mrq)6.15
Total debt (mrq)314M
Total debt/equity (mrq)12.19%
Current ratio (mrq)2.34
Book value per share (mrq)35.49

Cash flow statement

Operating cash flow (ttm)752.4M
Levered free cash flow (ttm)172.09M